Patents
Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
02/2009
02/05/2009WO2009016648A2 Process for the preparation of rocuronium bromide and intermediate thereof
01/2009
01/20/2009CA2304770C A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds
01/14/2009EP1497309B1 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
01/13/2009US7476727 Conjugates of mycophenolic acid
01/06/2009CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
12/2008
12/31/2008CN101333182A Allyl-substituted earth-proof imide compound, liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display unit
12/25/2008US20080317833 Novel Anti-Inflammatory Androstane Derivatives
12/24/2008WO2008155141A2 Novel facultative catonic sterols
12/24/2008EP2004669A1 Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
12/24/2008EP2004668A2 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
12/17/2008CN101323636A Preparation of rocuronium
12/11/2008US20080305049 Mri Contrast Agents for Diagnosis and Prognosis of Tumors
12/03/2008EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
11/2008
11/19/2008CN101307089A 2-imidazolyl-4-alkenyl-3-sterone and glyoxaline salt thereof and preparation method
11/19/2008CN101307088A Method for preparing cholic acid conjugates
11/13/2008US20080280864 3 beta -hydroxy-17-(1H-imidazole-1-yl)androsta-5,16-diene for treatment of prostate cancer; inhibitor of 17-alpha-hydroxylase/17,20 lyase/17,20 desmolase ( a cytochrome p-450 enzyme )
11/11/2008US7449572 Reducing compound such as 3,3-ethylenedioxyestra-5(10), 9(11)-dien-17-ol, halogenating, epoxidation, alkylation, deprotecting, aromatization, saponification, neutralization to obtain compound such as 11-beta-(4-(2-(1-piperidinyl)ethoxy)phenyl)-17-alpha-fluoroestra-1,3,5(10)-trien-3-ol
11/05/2008CN101300265A Nitrooxy derivatives of glucocorticoids
11/04/2008US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
10/2008
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/23/2008WO2008124922A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
10/23/2008CA2683522A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
10/22/2008CN101291950A 新系列咪唑基取代的类固醇和茚满-1-酮衍生物 New series of imidazolyl substituted steroidal and indan-1-one derivative
10/21/2008US7439250 such as lipoasparagine; liposomes
10/16/2008US20080255075 Treatment or inhibition of a steroid hormone dependent disorder; reducing spermatogenesis or male virility; 17 beta -hydroxysteroid dehydrogenase (17 beta-HSD) inhibitors; compounds such as 3-(benzylamino)-15alpha-(4-morpholin-4-yl-4-oxobutyl)estra-1(10),2,4-trien-17-one
10/15/2008CN100425621C Steroid imidazole salt compound and its preparing process
10/14/2008US7435816 A benzylidenegalactose-solasodine conjugate intermediate its preparation and its use in preparing solasonine
10/14/2008CA2379995C 11.beta.-aryl-17,17-spirothiolane-substituted steroids
10/09/2008US20080249075 C11 Modified Retrosteroids as Progesterone Receptor Modulator Compounds
09/2008
09/24/2008EP1971618A2 Modulators of hypoxia inducible factor-1 and related uses
09/16/2008CA2182228C Codrugs as a method of controlled drug delivery
09/12/2008WO2008109033A1 Steroid derivatives of fullerenes
09/10/2008CN101260136A Oestrogen derivatives as inhibitors of steroid sulphatase
09/04/2008US20080214514 Derivatives in which cholesterol or a cholesterol moiety is attached via ester, amide, or ether bonds to one of a variety of "linkers," e.g., chemical groups including alkyl chains and aromatic groups, which are then connected to fullerene moiety; steroid moiety confers solubility in biofluids; imaging
09/02/2008US7419780 invention relates to the evolution of enzymes in vivo, and drug screening in vivo through the use of chemical inducers of protein dimerization
08/2008
08/27/2008EP1408981B1 Methods for preventing antipsychotic-induced weight gain
08/26/2008CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
08/14/2008WO2007081835A3 Modulators of hypoxia inducible factor-1 and related uses
08/07/2008WO2008093086A1 Modulators of hypoxia inducible factor-1 and related uses
08/05/2008US7407947 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system
07/2008
07/29/2008US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
07/24/2008US20080177059 Free cholesterol analogs bearing a boron dipyrromethene difluoro (bodipy) fluorophore in the side chain and method of preparation and use thereof
07/23/2008EP1946007A2 Anbrosteeone derivatives and method of use thereof
07/23/2008CN101228177A 3-ester prodrugs of estradiol
07/22/2008CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
07/10/2008WO2007140380A3 Tagging reagents and methods for hydroxylated compounds
07/09/2008EP1940863A2 Nitrooxy derivatives op glucocorticoids
07/09/2008CN101218245A 3-ester prodrugs of ethynylestradiol
07/08/2008CA2384184C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
07/03/2008WO2008034796A3 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
07/02/2008CN100398109C Steroid derived antibiotics
06/2008
06/25/2008EP1934241A2 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives
06/25/2008EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives
06/19/2008US20080146531 Therapeutically Active Triazoles and Their Use
06/05/2008WO2008065100A1 Substituted estratrien derivatives as 17beta hsd inhibitors
06/05/2008CA2671075A1 Substituted estratrien derivatives as 17beta hsd inhibitors
06/03/2008US7381718 new process for the preparation of a key intermediate
06/03/2008CA2225382C Sialic acid derivatives
05/2008
05/28/2008EP1924592A2 Process for the synthesis of rocuronium bromide
05/28/2008CN101189251A 17 beta-HSD1 and STS inhibitors
05/21/2008EP1448591B1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations
05/21/2008EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
05/21/2008CN101182345A Ursolic acid oxazoline new drugs having antiphlogistic activity and preparation method thereof
05/20/2008CA2333668C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/20/2008CA2322862C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/15/2008US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances
05/13/2008CA2322847C Steroid derived antibiotics
04/2008
04/30/2008EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations
04/30/2008EP1664079B1 Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof
04/30/2008EP1444248B1 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
04/30/2008CN100384868C Oestrogen derivatives as inhibitors of steroid sulphatase.
04/17/2008WO2007118832A3 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
04/16/2008EP1910402A2 3-ester prodrugs of estradiol
04/16/2008EP1910401A2 3-ester prodrugs of ethynylestradiol
04/02/2008CN101155823A Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
03/2008
03/27/2008CA2663242A1 Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors
03/25/2008CA2383505C A process for the preparation of 3-amino bile acid derivatives
03/25/2008CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression
03/05/2008CN101134769A Ursodeoxycholic acid entecavir acidamide and preparation method and use thereof
02/2008
02/28/2008WO2007033348A3 Process for the synthesis of rocuronium bromide
02/27/2008CN101130567A Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
02/20/2008EP1888615A1 17 -hsd1 and sts inhibitors
02/20/2008CN101125878A Method for preparing steroid muscle relaxants rocuronium bromide
02/14/2008US20080039628 A benzylidenegalactose-solasodine conjugate intermediate its preparation and its use in preparing solasonine
02/07/2008WO2007073424A8 Pure rocuronium bromide
02/07/2008US20080032945 2'-modified oligonucleotides
02/05/2008CA2283597C Reduced cortisol conjugates
01/2008
01/29/2008CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
01/17/2008US20080015172 Caspase inhibitors and uses thereof
01/15/2008CA2319763C Cholenic acid amides and pharmaceutical compositions thereof
01/15/2008CA2123405C Angiostatic steroids
12/2007
12/26/2007CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
12/25/2007US7312206 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
12/19/2007CN101090908A Conjugates with anti-inflammatory activity
12/06/2007US20070282109 Process for the Preparation of 17-0-Vinyl-Triflates as Intermediates
12/05/2007EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
12/04/2007CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
11/2007
11/29/2007US20070275935 Estratriene Derivatives
11/28/2007EP1735330B1 Progesterone receptor modulators
11/22/2007US20070270584 Process for the Preparation of Steroidal Carbothioic Acid Derivatives and Intermediates
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 26